Accepting PhD Students

PhD projects

Factor VIII product “switch” and inhibitor development in patients with haemophilia A in Australia
Comparison of Contrast Enhanced Ultrasound to Magnetic Resonance Imaging for the detection of synovitis in patients with haemophilic arthropathy
Pedigrees, factor VIII genotype and patient progress in response to therapy (PROGENY)
Prevalence of Transfusion Acquired Hepatitis C in an Australian Bleeding Disorders Population
Tranexamic acid without prophylactic factor replacement for prevention of bleeding in patients with hereditary bleeding disorder undergoing endoscopy


Research activity per year

Personal profile


Dr Tran is currently appointed to the level of Adjunct Clinical Professor. He is Head of Haemostasis Thrombosis Unit and Director of the Haemophilia Treatment Centre (a state-wide service) at Alfred Health. The Alfred is a dynamic academic research organisation that is involved with basic science research and works to translate and integrate best evidence into routine standard of care, often in collaboration with The Australian Centre for Blood Diseases (ACBD) Monash University. Alfred Health is one of the premier organisations that thrives on delivering best care to complex patients.
Dr Tran is an active member of several research organisations, including the Haematology Clinical Research Unit (CRU), ACBD, Monash University, Thrombosis and Haemostasis Society of Australia and New Zealand (THANZ), and Australian Haemophilia Centres Directors’ Organisation (AHCDO). He has particular interests in the management of congenital haemophilia, venous thromboembolism (VTE) and its complications, rare bleeding disorders, immune platelet disorders and novel therapeutics. He has been the principal investigator for over 80 clinical trials in VTE diagnosis and management, haemophilia, and immune thrombocytopenia. He continues to supervise PhD (5), Master Phil (1), and numerous advanced haematology trainees.

He has a strong interest in standardising best practice and has led several published guidelines supported by specialty organisations in Australia, New Zealand and Asia Pacific regions. He is a strong supporter of medical education, training advanced haematology trainees (>30) and was a committee member of the Written Examination committee, Royal Australian College of Physicians (2008-15). He believes in the need to improve care in establishing countries and has lectured widely in the Asia-Pacific region, as well as, working with world federations societies for specific diseases. He is extremely active in AHCDO and THANZ, where he is the current Chair and Chair of the Clinical Trials Group (CTG) respectively. He works with governmental departments advisory boards and disease-specific advocacy groups to advocate for novel therapies to improve patient outcomes. He has a proven track record for leadership not only within Alfred Health but the wider community of haematology.

Related Links:

Clinical activities

Clinical focus & Service Provision

Diagnostic testing and treatment for patients with hereditary bleeding disorders began in 1954, and was incorporated into duties and service delivery from the laboratory haematology department. Services were redeveloped following the retirement of Dr Sawers and recognition of HIV infection in plasma recipients in 1984. It was subsequently recognised by the Department of Health as adult state centre for management of patients with hereditary bleeding disorders offering a multidisciplinary model of care that encompasses the diagnosis, treatment and long-term follow up. Currently, we are the only international haemophilia training centre in Australia.

The RSHC won the Twinning Centre of the year in 2013 by the World Federation of Haemophilia for educational work with the National Institute of Haematology and Blood Transfusion, Hanoi, Vietnam. Today approximately 1100 patients are registered with the centre and the number continues to rise. Prof Tran has led over 40 clinical trials since 2007.

Our comprehensive service includes Haemophilia and other hereditary bleeding disorders allowing the effective delivery of both inpatient and outpatient care.

We provide a consultative service to other specialties within The Alfred hospital. Patients are also referred to us for treatment from numerous centres within Melbourne and regional Victoria

Expertise related to UN Sustainable Development Goals

In 2015, UN member states agreed to 17 global Sustainable Development Goals (SDGs) to end poverty, protect the planet and ensure prosperity for all. This person’s work contributes towards the following SDG(s):

  • SDG 3 - Good Health and Well-being

Education/Academic qualification

Haematology, FRACP, Royal Australasian College of Physicians (RACP)

Award Date: 1 Jan 2003

Haematology, FRCPA, Royal College of Pathologists of Australasia (RCPA)

Award Date: 1 Jan 2003

External positions

Chair, Australian Haemophilia Clinical Directors Organisation (AHCDO)

1 Nov 2017 → …

Chair, Clinical Trials Group, Thrombosis and Haemostasis Society of Australia and New Zealand (THANZ)

1 Apr 2015 → …

Director, Haemophilia Treatment Centre, Alfred Health

1 Feb 2012 → …

President, Thrombosis and Haemostasis Society of Australia and New Zealand (THANZ)

1 Nov 20111 Oct 2013

Medical Director, Laboratory Haematology, Monash Health

1 Feb 20101 Jan 2012

Head, Haemostasis Thrombosis Services, Alfred Hospital

1 Dec 2009 → …

Thrombosis Research Fellow, McMaster University

16 Oct 20031 Dec 2005

Research area keywords

  • Thrombosis
  • Haematology

Collaborations and top research areas from the last five years

Recent external collaboration on country/territory level. Dive into details by clicking on the dots or